Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2

scientific article published on 01 March 1987

Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2 is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID3493293

P50authorSteven RosenbergQ2347448
P2093author name stringSachs D
Shiloni E
Eisenthal A
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectcytotoxicityQ246181
P304page(s)1992-1998
P577publication date1987-03-01
P1433published inJournal of ImmunologyQ3521441
P1476titleAntibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2
P478volume138

Reverse relations

cites work (P2860)
Q33370628A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group
Q37702283Anti-GD2 antibody therapy for GD2-expressing tumors
Q70541113Antitumor effects of recombinant interleukin-6 expressed in eukaryotic cells
Q40697616Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogs
Q55120894Combination therapy with antibody and interleukin-2 gene transfer against multidrug-resistant cancer cells.
Q68390239Cross linking of anti-B16 melanoma monoclonal antibodies to lymphokine activated killer (LAK) cells: possible role in the therapy of B16 melanoma
Q41586289Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro
Q68872691Effect of recombinant human tumor necrosis factor alpha on the induction of antibody-dependent cellular cytotoxicity in the treatment of established B16 melanoma liver nodules
Q67905595Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cells
Q37431356Immune therapies for neuroblastoma
Q68888663Indomethacin up-regulates the generation of lymphokine-activated killer-cell activity and antibody-dependent cellular cytotoxicity mediated by interleukin-2
Q55004458Inhibition of multidrug-resistant human tumor growth in athymic mice by anti-P-glycoprotein monoclonal antibodies.
Q67685133Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody
Q34377018Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis
Q54313350Monoclonal anti-P-glycoprotein antibody-dependent killing of multidrug-resistant tumor cells by human mononuclear cells.
Q33718831Monoclonal antibody-directed cytotoxic therapy: potential in malignant diseases of aging
Q33363235Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients
Q54977928Release of esterase from murine lymphokine-activated killer cells in antibody-dependent cellular cytotoxic reaction.
Q34186886The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma
Q39512710The development of new immunotherapies for the treatment of cancer using interleukin-2. A review
Q42183479Tumoricidal activation of murine resident peritoneal macrophages on pancreaticcarcinoma by interleukin-2 and monoclonal antibodies.
Q69674191Use of the subrenal capsule assay to measure antibody-dependent, cell-mediated cytotoxicity against head and neck tumors

Search more.